LINC02037

Across TCGA pan-cancer cohorts, LINC02037 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02037 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02037 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02037 expression acts as an unfavorable survival marker, although some lineages such as LIHC and UCS show a favorable association.

LIHC, MESO, and BRCA are the cancer types where LINC02037 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	II,III,IV	0.814	0.566	<.001	70	view →
MESO	DFS	Tertile	All	0.259	0.412	.004	60	view →
BRCA	DFS	Quartile	All	0.486	0.595	<.001	53	view →
CHOL	OS	Tertile	II,III,IV	0.175	0.679	.005	24	view →
UCS	OS	Median	All	0.759	0.565	.012	24	view →
LUAD	OS	Tertile	IV	0.169	0.654	.009	18	view →
STAD	DFS	Tertile	IV	0.101	0.524	.008	15	view →
KIRP	DFS	Median	All	0.788	0.891	.012	15	view →
ACC	DFS	Tertile	IV	0.068	0.402	.031	9	view →
KIRC	OS	Quartile	All	0.867	0.757	.025	4	view →
TGCT	DFS	Tertile	All	0.567	0.761	.043	4	view →
SARC	OS	Median	All	0.695	0.789	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC02037–LIHC (OS)

Open the LIHC breakdown →